MMedImpact is an independent pharmacy benefit manager serving health plans, self-funded employers, and government entities. It designs and administers prescription drug benefits, including formulary management, benefit design, utilization management, claims processing, clinical programs, and specialty drug management to cut costs and improve health outcomes. It differentiates itself as independent (not owned by a payer or drugstore) with transparent and flexible pricing across a broad client base and end-to-end benefit management. Its goal is to lower prescription drug costs for clients while improving member health through data-driven, transparent, and comprehensive programs.
Work here?Claim your company
Industries
Company Size
1,001-5,000
Company Stage
Seed
Total Funding
$2.8M
Headquarters
San Diego, CA
Founded
1989
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$2.8M
Below
Industry Average
Funded Over
2 Rounds
Industry standards
MedImpact adds rebate aggregator in latest PBM acquisition. The acquisition arrives as the Consolidated Appropriations Act, 2026 forces full rebate pass-through for the first time Nov 03, 2026 MedImpact, a San Diego-based independent pharmacy benefit manager (PBM), has signed an agreement to acquire the PBM assets of VytlOne, including its affiliate Gateway Health Partners, one of the market's leading third-party vendors managing rebate aggregation for smaller PBMs. The deal, announced on October 26, adds a rebate aggregator to MedImpact's portfolio at a moment when federal law has put that layer of the drug supply chain under its most intense scrutiny yet. VytlOne President Amy Garrigues, writing to clients on the day the deal was announced, said the transaction does not include VytlOne's 340B, specialty pharmacy, or pharmacy fulfillment assets, which the company will retain. She said MedImpact's scale and clinical capabilities "will provide even more choice and flexibility, additional tools to manage pharmacy costs and continued support for the best member experience." A busy year of deals. The agreement is MedImpact's fourth significant transaction since February 2026. The San Diego-based company completed its acquisition of Sav-Rx, a PBM serving organized labor, in February, then acquired risk management firms MHW Benefit Partners and MSL Captive Solutions in March. The VytlOne PBM deal is subject to customary regulatory review. Terms were not disclosed. The company has also been active in prior years.In February 2024, it acquired Elixir Solutions from Rite Aid for approximately $576.5 million. What the Gateway acquisition means under the new law. Gateway's function is what makes this deal worth watching closely. Rebate aggregators sit between drug manufacturers and PBMs, pooling claims from multiple plans to negotiate manufacturer rebates. Smaller PBMs have historically relied on them to access pricing leverage they could not achieve independently. That dynamic also makes it difficult for employer plan sponsors to see exactly how much of a rebate they are actually receiving. The Consolidated Appropriations Act, 2026, signed into law on February 3, directly targets this opacity. Under the new federal requirements, PBMs and the rebate aggregators and group purchasing organizations they contract with must pass through 100% of rebates and related remuneration to group health plans on a quarterly basis, according to a Morgan Lewis analysis of the legislation. Semiannual reporting to plan sponsors on drug pricing, rebate flows, and compensation arrangements becomes mandatory, and plan sponsors gain annual audit rights over their PBM. Most requirements take effect for calendar-year plans on January 1, 2029. Plan sponsors and the benefits advisers who serve them are now, for the first time, entitled by law to see the full economics of their PBM relationships, including the aggregator layer.
MedImpact Acquiring the PBM Assets of VytlOne, including Gateway Health Partners. MedImpact, a San Diego-based independent pharmacy benefit manager (PBM), has signed an agreement to acquire the PBM assets of VytlOne, including its affiliate Gateway Health Partners, one of the market's leading third-party vendors managing rebate aggregation for smaller PBMs. The deal, announced on October 26, 2026, adds a rebate aggregator to MedImpact's portfolio. Amy Garrigues. President, VytlOne on Oct 26, 2026 writing to clients: I'm writing to share that VytlOne has signed an agreement for MedImpact to acquire its PBM and its affiliate Gateway Health Partners. The proposed transaction does not include VytlOne's 340B or pharmacy fulfillment assets. Access Market Intelligence believe this agreement creates a strong path forward for its PBM clients and members. MedImpact shares its commitment to making pharmacy benefits work better and brings more than 40 years of experience as an independent PBM. Its scale, technology and advanced clinical capabilities will provide even more choice and flexibility, additional tools to manage pharmacy costs and continued support for the best member experience. MedImpact is developing more flexible options that provide plan sponsors with greater visibility into pharmacy economics and better align PBM incentives with their goals. Combined with VytlOne's clinical expertise and best-in-class client service and operations, these capabilities would create meaningful long-term value for your organization. Earlier this year, MedImpact announced the completion of its acquisition of Sav-Rx, a pharmacy benefit manager with more than five decades of experience serving organized labor. The transaction strengthens MedImpact's ability to serve a broad range of clients by adding specialized expertise, scale, and deep insight into a key market segment. Sav-Rx will continue to operate independently, with no changes to its leadership or its long-standing service model. #MedImpact #PBM #VytlOne #GatewayHealthPartners #Sav-Rx #rebate #aggregator
MedImpact launches Claria, a new approach to transform PBM economics. Serving more than 20 million members and processing more than $40 billion in pharmacy transactions annually, MedImpact has the scale, resources, technology, and solutions to provide payers a better choice in the market for pharmacy benefits and health solutions. MedImpact recently introduced Claria, an industry-first approach that transforms PBM economics by giving plan sponsors the increased transparency, control, and predictability they need to confidently manage pharmacy spend in today's healthcare landscape. The company believes payers should not choose between rebates, flexibility, and financial certainty. That's why Claria offers four configurable models, all with transparent pricing, to meet each organization's unique needs: * Claria Direct - Designed for organizations that want to maximize control over their pharmacy strategy, Claria Direct offers the ability to customize formularies, networks, dispensing channels, and value-added services. * Claria Assure - Offers modernized pricing strategies with the flexibility to customize program features all with the financial confidence of guarantees. * Claria One - A PMPM guarantee and a formulary strategy built around lower-cost therapeutic options designed for organizations seeking the highest level of financial accountability and cost management. * Claria Align - By guaranteeing a plan's PMPM spend dollar for dollar, Claria Align delivers the highest level of accountability in the portfolio and is designed to deliver the lowest pharmacy costs. In August 2026, Yahoo Finance reported that MedImpact was in talks to receive a $2.2 billion second-lien private credit loan to support the company's proposed acquisition of Medical Card System, a healthcare services organization. Medical Card System, owned by Kinderhook-backed MHH Healthcare, offers insurance plans and managed care for Medicare Advantage members in Puerto Rico. #MedImpact #PBM #Claria #pharmacybenefit #transparency #medicalcardsystem
MedImpact launches Claria(TM), a distinctively new approach to delivering pharmacy benefits. * 5 hrs ago MedImpact, the nation's largest independent pharmacy benefit and health solutions company, today introduced Claria(TM), an industry-first approach that transforms PBM economics by giving plan sponsors the increased transparency, control, and predictability they need to confidently manage pharmacy spend in today's healthcare landscape. "Claria provides a new way of delivering pharmacy benefits to our clients. It brings together the scale of MedImpact's organization to deliver competitive economics with the flexibility for clients to choose the model that meets their needs. Most importantly, Claria is designed to align our compensation with our clients' goals of managing pharmacy spend, controlling trend, and improving access to care," said MedImpact Executive Vice President Zach Johnson. "Plan sponsors gain visibility into the true net cost of medications, greater control over clinical strategies, and enhanced budget predictability." Predictability Without Compromise. Mycarrollcountynews believe payers should not have to choose between rebates, flexibility, and financial certainty. That's why Claria offers four configurable models, all with transparent pricing, to meet each organization's unique needs: * Claria Direct - Designed for organizations that want to maximize control over their pharmacy strategy, Claria Direct offers the ability to customize formularies, networks, dispensing channels, and value-added services. * Claria Assure - Offers modernized pricing strategies with the flexibility to customize program features all with the financial confidence of guarantees. * Claria One - A PMPM guarantee and a formulary strategy built around lower-cost therapeutic options designed for organizations seeking the highest level of financial accountability and cost management. * Claria Align - By guaranteeing a plan's PMPM spend dollar for dollar, Claria Align delivers the highest level of accountability in the portfolio and is designed to deliver the lowest pharmacy costs. Informed Decision Making. Claim-level rebate transparency provides visibility into the net cost of every medication, enabling more informed financial and clinical decision-making. Plan Control Over Pharmacy Strategy. Plans may implement formulary, utilization management, biosimilar, and network strategies based on their organization's needs. Aligned Incentives. Claria aligns PBM compensation with services and solutions rather than drug mix, creating a stronger partnership with a continued focus on managing cost, trend, and outcomes. Member Affordability. Mycarrollcountynews recognize that its clients value and prioritize affordable pharmacy benefits for their members. Claria will position MedImpact to lay the foundation that aligns and empowers Mycarrollcountynews to build pharmacy plans that prefer the lowest cost, and therapeutically appropriate medication now more than ever. "MedImpact has been an independent company for nearly 40 years, and we have been committed to delivering clarity and control to our clients since our inception," said Johnson. "With Claria, we are taking that commitment to an entirely new level and providing clients with even greater flexibility and freedom to navigate today's healthcare landscape." About MedImpact San Diego-based MedImpact Healthcare Systems, Inc. is the nation's largest independent health solutions, technology, and pharmacy benefit management provider. For 35 years, MedImpact has helped commercial and government healthcare payers improve member health, manage benefits, and reduce drug costs. Today, MedImpact serves more than 20 million members and processes more than $40 billion in pharmacy transactions annually. To learn more, visit Mycarrollcountynews online, follow Mycarrollcountynews on LinkedIn, or contact Mycarrollcountynews at [email protected]. Media gallery
MedImpact names Rebekah Gregg Senior Vice President of Marketing and Digital Solutions. Pharmacy benefits executive will help the company communicate its affordability, technology, and clinical solutions to a healthcare industry undergoing change SAN DIEGO, CA - September 24, 2026 - MedImpact, the nation's largest independent pharmacy benefit and health solutions company, has named Rebekah Gregg Senior Vice President of Marketing and Digital Solutions. Gregg joins as MedImpact brings to market new solutions that give healthcare payers greater visibility, choices, and control over pharmacy benefits and lower costs for both members and plans. "Rebekah has spent much of her career working closely with payers and knows what challenges our clients face, what they need, and how to communicate it clearly," said MedImpact Executive Vice President Zach Johnson. "Her timing is excellent. We have exciting work underway and she is the right person to help us bring new solutions to the market." Payers today are facing rising drug prices, new therapies with historically high price tags, changing regulatory and marketplace dynamics, and an affordability crisis for members at the counter. An independent company for nearly 40 years, MedImpact is taking bold action by re-engineering the drug supply chain and rolling out new technologies, formularies, models, and clinical programs. Rebekah's expertise will be critical in communicating the value of the company's innovative solutions to the marketplace. Gregg joins MedImpact from Pharmaceutical Strategies Group (PSG), an EPIC company, where she served as Chief Operating Officer. In that role, she oversaw marketing, research, and operations, and an analytics platform that was used by payers covering more than 16 million members. She also led the firm's research and satisfaction studies, giving her a close view of what plan sponsors look for in pharmacy benefit partners. Keep up to date on the latest in the industry. Press Releases Claria transforms PBM economics by giving plan sponsors the transparency, control, and predictability they need to maximize their investment in medications Press Releases HCG X program provides payers 80.6% PMPQ savings and a 5:1 ROI in year one Press Releases Leveraging supply chain innovation and award-winning lifestyle management program, new solutions deliver lower costs, improved clinical care, and greater member access Press Releases By re-engineering the drug supply chain and formularies, Patel and the MedImpact team are increasing transparency, predictability and affordability
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs
Industries
Company Size
1,001-5,000
Company Stage
Seed
Total Funding
$2.8M
Headquarters
San Diego, CA
Founded
1989
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs